12.5mg-blister (12.5mg Blister)
Paroxetine Hydrochloride
Product Images NDC 69986-017
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 69986-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sinotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
12.5mg-bottle (12.5mg Hdpe)
25mg-blister (25mg Blister)
25mg-bottle (25mg Hdpe)
37.5mg Hdpe
Description: This text appears to be a label or description of a medication called Paroxetine Extended-Release Tablets. It contains information about the dosage (37.5mg), storage instructions, and the manufacturer's address. The text also mentions the need to dispense an accompanying Medication Guide to each patient. The product appears to be manufactured by Sinotherapeutics Inc. and Haimen Pharma Inc., located in Shanghai and Jiangsu, China, respectively.*
Figure1 (Figure 1)
Figure2 (Figure 2)
Figure3 (Figure 3)
This text provides information about the population description, including details about renal impairment levels (mild, moderate, severe) and hepatic impairment. It also mentions dose recommendations for individuals over 65 years of age and different gender groups (males). Additionally, there is a mention of fold change and a 90% confidence level, with a relative change of 50.0 compared to the reference.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
